Word

D

Status

Pending

Status Code

653

Status Date

Wednesday, July 17, 2024

Serial Number

97229686

Mark Type

3

Filing Date

Thursday, January 20, 2022

Trademark Owner History

Diamond Therapeutics Inc.

Classifications

40 Custom manufacture for others of pharmaceuticals, pharmaceutical drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; custom manufacture for others of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to treat mental conditions, illnesses and disorders

9 Downloadable computer applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer applications for use in therapy of cognitive states; downloadable computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer software applications for use in therapy of cognitive states; medical systems comprising recorded and downloadable software and/or hardware for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical systems comprising recorded and downloadable software and/or hardware for use in therapy of cognitive states; downloadable software as a Medical Device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable software as a Medical Device (SaMD) for use in therapy of cognitive states; downloadable software as a Medical Device (SaMD) for stimulating nerves

39 Warehousing services namely, storage, distribution, pick-up and packing for shipment of pharmaceuticals, pharmaceutical drugs, therapeutics, and health care products, namely, central nervous system health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments

5 Pharmaceutical preparations for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical products for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical preparations for the treatment of mental conditions, illnesses, and disorders; pharmaceutical drugs for the treatment of mental conditions, illnesses, and disorders; psychedelic pharmaceuticals for the treatment of central nervous system conditions, illnesses, and disorders; psychedelic-based medicines for the treatment of central nervous system conditions, illnesses, and disorders; neurogenerative pharmaceutical drugs; serotonin receptor agonists and antagonist pharmaceutical drugs; drug abuse deterrent products in the nature of low-dose pharmaceutical preparations and products and health care products, very low-dose pharmaceutical preparations and products, and health care products, extended release pharmaceutical preparations and products and health care products, and tamper resistant pharmaceutical preparations and products and health care products; pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms, namely, motivation, attention, accuracy, response speed, perseverance, cognitive engagement, executive function, mood, and/or behavior; pharmaceutical preparations and products and health care products for the treatment of mental conditions, illnesses, and disorders

35 Wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses and disorders

45 Licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses, and disorders

10 Electroencephalogram (EEG) devices, namely, electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes; medical devices for monitoring, sensing, measuring, and training brain and neural activity; medical devices for use in therapy of cognitive states, namely, to monitor, sense, or measure cognitive impairment; medical devices for stimulating nerves; medical device used for treating of mental health disorders non-invasively, namely, comprising a sensor for monitoring and measuring brain and neural activity; medical device used for treating of mental health disorders non-invasively, namely, for monitoring, sensing, stimulating, measuring, and training brain and neural activity

42 Pharmaceutical research and development; pharmaceutical drug development; pharmaceutical research and development in the field of mental health treatments; drug discovery services; consultancy pertaining to pharmacology; medical research in the field of mental health conditions, illnesses, and disorders; neuropsychiatric drug discovery services, including pre-clinical and clinical pharmaceutical drug development; pharmaceutical drug development and discovery relating to new chemical entities, neurogenerative drugs, serotonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms

The mark consists of upper case letter D with a diamond shape positioned along its vertical spine.

Trademark Events

Jan 24, 2022

New Application Entered

Feb 2, 2022

New Application Office Supplied Data Entered

Feb 3, 2022

Notice Of Design Search Code E-Mailed

Oct 29, 2022

Assigned To Examiner

Nov 3, 2022

Non-Final Action Written

Nov 3, 2022

Non-Final Action E-Mailed

Nov 3, 2022

Notification Of Non-Final Action E-Mailed

May 3, 2023

Teas Response To Office Action Received

May 3, 2023

Correspondence Received In Law Office

May 4, 2023

Teas/Email Correspondence Entered

May 24, 2023

Non-Final Action Written

May 24, 2023

Non-Final Action E-Mailed

May 24, 2023

Notification Of Non-Final Action E-Mailed

Aug 18, 2023

Teas Response To Office Action Received

Aug 18, 2023

Correspondence Received In Law Office

Aug 19, 2023

Teas/Email Correspondence Entered

Mar 15, 2024

Suspension Checked - To Attorney For Action

Apr 4, 2024

Suspension Inquiry Written

Sep 14, 2023

Suspension Letter Written

Sep 14, 2023

Letter Of Suspension E-Mailed

Sep 14, 2023

Notification Of Letter Of Suspension E-Mailed

Apr 4, 2024

Inquiry To Suspension E-Mailed

Apr 4, 2024

Notification Of Inquiry As To Suspension E-Mailed

Jun 26, 2024

Teas/Email Correspondence Entered

Jun 26, 2024

Teas Response To Suspension Inquiry Received

Jul 17, 2024

Letter Of Suspension E-Mailed

Jul 17, 2024

Notification Of Letter Of Suspension E-Mailed

Jul 17, 2024

Suspension Letter Written

Jun 26, 2024

Correspondence Received In Law Office